Kaushik Sadhukhan, Subhrajyoti Naskar, Dhritashree Mandal


AIM: To see the effect of intravitreal Ranibizumab in Epiretinal membrane(ERM).

METHODOLOGY: 12 patients were selected in our study and intravitreal Ranibizumab(0.5 mg) was injected to respective eye of each patient for 3 consecutive doses at 1 month interval after prior informed consent and instituitional clearance. Best corrected visual acuity(BCVA) and intraocular pressure(IOP) measurement along with detailed fundal evaluation under mydriasis by using 78D,90D lens,indirect ophthalmoscopy and central macular thickness measurement by spectral domain optical coherence tomography(SD-OCT) were performed both before intervention and after intervention at 1 month interval upto 6 months after last injection in both eyes. Central macular thickness reduction more than 100 microns from baseline value after 6 months of last injection was considered as clinically significant. The data were then analysed by paired t test using SPSS software.

RESULTS: Out of 12 patients, 7 had shown reduction in membrane thickness as evidenced by central macular thickness reduction of more than 100 microns after 6 months of last injection from baseline value.

CONCLUSION: Intravitreal Ranibizumab can be a handy tool in the management of epiretinal membreane but can not replace pars plana vitrectomy(PPV) as first choice therapy.


Epiretrinal membrane, Best corrected visual acuity, Central macular thickness, Spectral domain optical coherence tomography, Pars plana vitrectomy, Vascular endothelial growth factor.

Full Text:



Smiddy W.E, Michels R.G., Green W.R. Morphology, pathology, and surgery of idiopathic vitreoretinal macular disorders. A Review Retina. 1990;10:288-296.

Saran B.R., Brucker A.J. Macular epiretinal membrane formation and treated retinal breaks. Am J Ophthalmol. 1995; 120:480-485.

Halfer WS, Aturaliya U. Macular puckers after retinal detachment surgery. Br J Ophthalmol1971; 55:451-57.

Carney MD, Jampol LM. Epiretinal membranes in simple cell retinopathy. Arch Ophthalmol 1987;105:214-17.

Pearlstone A.D., The incidence of idiopathic preretinal macular gliosis. Ann Ophthalmol 1985; 17:378-80.

Smiddy W.E., Michels R.G., Gilbert H.D., Green W.R. Clinicopathological study of idiopathic macular pucker in in children and young adults. Retina. 1992:232-236.

Banach M.J., Hassan T.S., Cox M.S., Margherio R.R., Williams G.A., Garretson B.R.Clinical course and surgical treatmentof macular epiretinal membranes in young subjects. Ophthalmology. 2001;108:23-26.

Sidd R.J., Fine S.L., Owens S.L., Patz A. Idiopathic preretinal gliosis. Am J Ophthalmol.1982;79:366-373.

Appiah A.P., Hirose T., Kado M. A review of 324 cases of idiopathic premacular gliosis. Am J Ophthalmol. 1988;15:533-535.

Chen Y.S., Hackett S.F., Schoenfelds C.L., Vinores M.A., Vinores S.A., Campochiaro P.A., Localisation of vascular endothelial growth factorand its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol. 1997;81:919-926.

Tsanou E., Loachim E., Stefanioyou M. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes Int J Clin Pract. 2005;10:1157-1161.

Gass JDM. Stereoscopic Atlas of Macular Disease: Diagnosis and Treatment , St Louis: The CV Mosby Co 1987.

Arroyo JG, Irvine AR,. Retinal distorsion and cotton wool spots associated with epiretinal membrane contraction. Ophthalmology 1995;102(4):662-668.

Allen A W Jr, Gass JDM: Contraction of perifoveal epiretinal membrane simulating a macular hole. Am J Ophthalmol1976;82:684-91.

Immonen J, Vaheri A, Tommila Pet al. Plasminogen activation in epiretinal membranes. Graefes Arch Clin Exp Ophthalmol


  • There are currently no refbacks.